Alexandre Cochet has received the Marie Curie Award from the European Association of Nuclear Medicine (EANM), a prestigious distinction recognising high-quality scientific research presented at its annual congress.
His work, entitled “Impact of [18F]Fluoroestradiol (FES) PET/CT on Second-Line Treatment Decision in Patients with ER+ HER2- Metastatic Breast Cancer: Results from the ESTROTIMP Trial”, investigates the contribution of fluoroestradiol PET/CT imaging to treatment decision-making in patients with oestrogen receptor-positive metastatic breast cancer.
This international distinction recognises the quality of his research and its contribution to advances in nuclear medicine. The Institute congratulates Alexandre Cochet on this achievement.
Photo: Dr. Romain-David Seban (Institut Curie), Pr. Jean-Louis Alberini (CGFL/ICMUB), Pr. Alexandre Cochet (CGFL/ICMUB), Pr. Emmanuel Deshayes (Institut du Cancer de Montpellier)